Successful Treatment of Vincristine Induced Unilateral Ptosis with Pyridoxine and Pyridostigmine in a Child with Langerhans Cell Histiocytosis (LCH)
Kamuran Karaman 1 * , Sinan Akbayram 1, Mesut Garipardıç 1, Ahmet Fayık Öner 1
More Detail
1 Department of Pediatric Hematology, YuzuncuYil University Faculty of Medicine, Van, Turkey
* Corresponding Author


We report the case of a 2-year-old boy with langerhans cell histiocytosis who developed vincristine (VCR)-induced unilateral ptosis and recovered on treatment with pyridoxine and pyridostigmine. He was treated with LCH TRAIL (Initial treatment) chemotherapy regimen. Two days after the fifth dose of VCR, he presented with unilateral ptosis. VCR as an antineoplastic drug causes neurotoxicity frequently. Neurological examination revealed unilateral ptosis, without pupillary or other oculomotor dysfunction. The other cranial nerves and peripheral nerves examinations were normal. Cranial magnetic resonance imaging and cerebrospinal fluid examination were normal. The unilateral ptosis markedly improved after two weeks of pyridoxine and pyridostigmine treatment and completely resolved after 3 weeks and there was no further recurrence of ptosis on follow up.


This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Case Report

EUR J GEN MED, 2016 - Volume 13 Issue 1, pp. 67-69

Publication date: 16 Jan 2016

Article Views: 815

Article Downloads: 878

Open Access References How to cite this article